Ecolab ECL has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 5 | 2 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 1 | 1 | 0 | 0 |
2M Ago | 1 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 4 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $218.75, with a high estimate of $238.00 and a low estimate of $210.00. This current average reflects an increase of 8.16% from the previous average price target of $202.25.
Diving into Analyst Ratings: An In-Depth Exploration
A clear picture of Ecolab's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Jeffrey Zekaukas | JP Morgan | Raises | Neutral | $220.00 | $200.00 |
Ashish Sabadra | RBC Capital | Raises | Outperform | $238.00 | $213.00 |
Steve Byrne | B of A Securities | Raises | Neutral | $216.00 | $185.00 |
Joshua Spector | UBS | Raises | Buy | $227.00 | $211.00 |
Ashish Sabadra | RBC Capital | Maintains | Outperform | $213.00 | - |
Ashish Sabadra | RBC Capital | Maintains | Outperform | $213.00 | - |
Ashish Sabadra | RBC Capital | Maintains | Outperform | $213.00 | - |
Pavel Molchanov | Raymond James | Announces | Outperform | $210.00 | - |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ecolab. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Ecolab compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Ecolab's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Capture valuable insights into Ecolab's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Ecolab analyst ratings.
Delving into Ecolab's Background
Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management solutions across its end markets. The company has a strong hold on the U.S. market and is growing its presence abroad.
Ecolab: A Financial Overview
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Ecolab's remarkable performance in 3 months is evident. As of 30 September, 2023, the company achieved an impressive revenue growth rate of 7.87%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Ecolab's net margin excels beyond industry benchmarks, reaching 10.21%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Ecolab's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.26%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Ecolab's ROA stands out, surpassing industry averages. With an impressive ROA of 1.87%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.17, caution is advised due to increased financial risk.
Analyst Ratings: Simplified
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.